LEVI GARRAWAY was named senior vice president, Global Development & Medical Affairs, for Eli Lilly and Co.‘s Oncology business. He will succeed Richard Gaynor, who is retiring, on Jan. 1, 2017. Garraway is an associate professor of medicine in the Department of Medical Oncology at the Dana-Farber Cancer Institute and Harvard Medical School, an associate...
Over the course of his first six months as NCI director, Anthony Letai has contended with federal budget turbulence, a record-setting government shutdown, and concerns about the flow of over research dollars.
